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The possibility of inducing peritoneal inflammation in
three murine species (gerbils, rats and mice) via the oral
administration of indomethacin was investigated with the
overall aim of developing an experimental animal model
for human peritonitis. Gerbils given high doses of
indomethacin at a rate of 30 mg and 40 mg/kg body
weight showed swelling of the abdomen, depression and
dyspnea within 4 days after the treatment. The severity of
the clinical symptoms increased with time. The animals
were confirmed as having developed peritonitis based on
the pathological features including inflammation of the
peritoneum, and fibrinous adhesion of the abdominal
organs in the abdominal cavity. The severity of peritonitis
increased with increasing dose of indomethacin, and was
not related to the gender of the animal. On the other hand,
peritoneal inflammation did not develop in the rats and
mice even at high doses. Therefore, the administration of
30 mg/kg body weight of indomethacin is an effective and
simple method of inducing peritonitis in 5-week-old
Mongolian gerbils.  The animal peritonitis model used in
this study can be used as an effective tool for examining
potential therapeutic compounds for preventing peritoneal
damage during peritonitis, and provide insight into the
pathophysiology of peritonitis.
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Introduction
Peritonitis is inflammation of the peritoneum. It is
different from the inflammatory changes brought about by
this condition, and is followed by acute changes in the
function of the peritoneum. Peritonitis still continues to be
one of the major abdominal emergencies causing high in-
hospital morbidity and mortality rates of up to 38%. The
mechanism for peritonitis is not well established, but its
clinical consequences can be quite devastating [4,5,12]. The
intraperitoneal administration of live bacteria such as E. coli
results in septic peritonitis, with diaphragmatic lymphatic
clearance, and systemic bacteremia and endotoxemia [7,8].
In addition, it has been reported that chronic peritoneal
inflammation can be induced by an intraperitoneal inoculation
of chemical stimuli such as cyanate [11]. However, although
these reports have provided valuable information, an animal
model with little clinical importance was used in those
studies because direct intraperitoneal approaches using these
pathogens rarely occur. Although experimental peritonitis
was induced by an intraperitoneal injection of several
substances, including bacteria [14,18] and chemical stimuli
[6,19], the precise mechanism leading to peritonitis is
unknown. The lack of a suitable in vivo model for peritonitis
has hampered studies aimed at clarifying the mechanism
and establishing treatments for peritonitis. Therefore, a
convenient and reproducible murine animal model is needed
for experimental peritonitis. The overall aim of this study
was develop an experimental model for peritoneal inflammation
in a murine species using an oral dose of indomethacin.
Materials and Methods
Animals
Specific pathogen-free (SPF) 5-week-old male and female
ICR mice and SPF 5-week-old male and female Sprague-
Dawley (SD) rats were purchased from Samtako (Osan,
Korea). In addition, SPF 5-week-old male and female
Mongolian gerbils (Meriones unguiculatus) were obtained
from the SPF Animal Facilities, College of Medicine, Seoul
National University, Korea. All the animals were allowed to
acclimatize in the inspection facility for 1 week before the
experiments. Thereafter, the animals were kept in an isolated
SPF barrier room with a regulated temperature (23 ± 1
oC),
humidity (50 ± 5%) and light/dark cycle (12/12 h). The
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animals were fed a pellet diet sterilized with 2 M rad
radiation (Purina, Korea) and sterilized water ad libitum. All
the studies were performed in accordance with the Guide for
Animal Experimentation, Seoul National University and
were approved by the Institutional Animal Care and Use
Committee of Seoul National University. All efforts were
made to minimize the level of pain or discomfort of the
animals.
Experimental design
Twenty-four Mongolian gerbils were divided into four
groups. Each group consisted of both males (n = 3) and
females (n = 3). The gerbils in group 1 received an oral dose
of 1% carboxy methyl cellulose (CMC; Aldrich, USA). The
gerbils in the other groups were dosed orally with different
concentrations of indomethacin (Fluka GmbH, Switzerland).
The concentrations were 20 mg (group 2), 30 mg (group 3)
and 40 mg (group 4) per animal body weight in kg
suspended in 1% CMC. In the case of the ICR mice and SD
rats, the animals were divided into four groups per species
and treated with indomethacin in the same manner as
described above for the gerbil experiment.
Monitoring of clinical signs, urine analysis and blood
sampling
The clinical signs of the animals were assessed twice daily
after administering the indomethacin. The animals were
sacrificed 5 days after the initial dose. Prior to sacrifice,
urination was stimulated by palpation of the lower abdomen,
and urinalysis was performed using reagent strips (Multistix
10 SG; Bayer, USA) according to the manufacturer’s
instruction. The animals were then anesthetized by the
inhalation of diethyl ether (Samchun, Korea). The abdomen
was then opened, and blood was withdrawn from the lower
caval vein using a sterile syringe, transferred to tubes
containing 15% EDTA (K3) and immediately cooled on ice.
The blood was used for hematology and chemical analyses.
Plasma for these analyses was collected by centrifugation at
3,000 × g for 10 min at 4
oC, and aliquots were stored at −20
oC.
Macroscopic and histopathological analysis
Shortly after blood sampling, the animals were sacrificed
by a cervical dislocation. After a careful macroscopic inspection,
samples from peritoneum and other parenchymatous organs
were removed, fixed in 10% buffered neutral formalin, and
embedded in paraffin for routine histopathological processing.
Four-micron thick sections were stained with hematoxylin
and eosin. Two independent investigators, who were blinded
to the groups, performed the histopathological examination
on coded samples. The level of inflammation and damage
was scored by screening each entire peritoneum or the
following parameters: fibrosis, inflammatory cell infiltration,
and edema. Each parameter was graded on a scale from 0 to
3 as follows: 0, absent; 1, mild; 2, moderate; and 3, severe.
The total histopathology score is expressed as a sum of the
scores for all parameters. In addition, a histopathology
observation was performed on the other parenchymatous
organs including the liver, stomach, duodenum, jejunum,
ileum, colon, lung, heart, spleen, urinary bladder, kidney,
thymus, adrenal gland, cerebellum and cerebrum.
Hematological and biochemical analysis
Hematological analysis was performed using an automatic
counter (ADVIA 120; Bayer, USA) according to the
manufacturer’s instructions. Serum biochemical analysis of
the gerbils was performed using an automatic analyzer
(DRI-CHEM FDC3500; Fuji, Japan) according to the
manufacturer’s protocol.
Statistical analysis
Data are reported as mean ± SD. For statistical analysis,  t-
test was used to analyze the data by MINITAB software
(Minitab, USA). Values of p< 0.05 were considered significant.
Results
Mongolian gerbils
The Mongolian gerbils in the groups given high indomethacin
doses (30 mg/kg group 3 and 40 mg/kg group 4) showed
swelling of the abdomen, depression and dyspnea within 4
days after treatment. In group 4, two gerbils died on day 5.
The severity of the clinical symptoms increased with time.
The Mongolian gerbils showing clinical symptoms were
necropsied on the 5th day after the initial oral dose. The
sacrificed animals were subjected to macroscopic and
histology analyses. The animals were confirmed as having
developed peritonitis based on the pathological features of
the abdominal cavity. The severity of peritonitis increased
with increasing indomethacin dose and was not related to
gender. The macroscopic findings consisted of abdominal
swelling, ascites, swelling of the colon and fibrinous
adhesion of the abdominal organs (Fig. 1a). The parietal
peritoneum was thickened and the digestive tracts were
covered with a thin fibrinous film. The liver had a dark color
with whitish patches and a dull edge. The gastrointestinal
loops adhered to each other along the entire length (Fig. 1b).
The mesentery was contracted and thickened. Figures 2a
and 2b show the histopathological findings in the
peritoneum of the gerbils belonging to groups 3 and 4 five
days after the oral administration of indomethacin,
respectively. The parietal peritoneum was thickened and
edema was observed under the mesothelium. Fibrosis also
progressed under the mesothelium with the infiltration of
mononuclear cells (Fig. 2a & b). The histopathological
scores shown in Table 1 were higher in group 3 and 4 than in
group 2. Inflammatory lesions were observed mainly on
their serous surfaces of the other abdominal organs. The
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membrane mainly due to collagen deposition and fibrosis
(Fig. 2c). There was fibrosis of the visceral peritoneum and
infiltration of mononuclear cells in the pancreas of these
animals (Fig. 2d). Similarly, the animals of groups 3 and 4
showed dark red and sticky material in the jejunum, ileum
and enlarged colon. Histopathologically, the jejunum of
these animals contained mucosal erosions and hemorrhagic
lesions. The animals belonging to the groups given the high
dose showed regenerative gastric ulcers in the stomach.
However, there were no significant lesions in the other
parenchymal organs including the kidney, heart and lung.
The animals in group 2 showed mild histopathological
changes in the peritoneum (Table 1).
The animals in groups 3 and 4 showed hematological
changes such as a significant increase (p < 0.05) in the white
blood cell count and a significant decrease (p < 0.05) in the
platelet count (Table 2). Biochemical analysis showed a
decrease in the total protein and albumin level with a
significant increase (p < 0.05) in the alanine transaminase
(ALT), asparate transaminase (AST), and blood urea
nitrogen (BUN) and creatinine levels (Table 3). Urinalysis
revealed mild protein loss.
Fig. 1. A representative Mongolian gerbil treated with high-
dosed indomethacin is shown. The macroscopic findings were a
swelling of the abdomen, ascites, a swelling of the colon an d
fibrinous adhesion of the abdominal organs (a). The gastrointestina l
loops adhered to each other along their entirety (b).
Fig. 2. Histopathological findings of a gerbil given a high dose d
of indomethacin. The parietal peritoneum was thickened
including edematous changes, and the fibrosis infiltration o f
mononuclear cells was observed (a, b). H&E stain, ×200. The
liver showed a thickened serous membrane mainly due to
collagen deposits and fibrosis (c). H&E stain, ×400. In the
pancreas, there was fibrosis of the visceral peritoneum and the
infiltration of mononuclear cells (d). H&E stain, ×400. 
Table 1. Histopathological scores of peritoneal inflammation on 5 days after oral administration of indomethacin
Species
Indomethacin (mg/kg body weight)
02 0 3 0 4 0
Male Female Male Female Male Female Male Female
Gerbils 0 0 2.1 ± 1.43* 1.9 ± 1.65* 7.8 ± 2.03* 8.2 ± 2.17* 8.1 ± 1.84* 8.3 ± 2.15*
I C R  m o u s e 00000000
S D  r a t 00000000
Note: To score inflammation and damage, each entire peritoneum was screened for the following parameters: fibrosis, inflammator y cell infiltration,
and edema. Each parameter was graded on a scale from 0 to 3, as follows: 0, absent; 1, mild; 2, moderate; and 3, severe. The to tal histopathological
score was expressed as the sum of the scores for all parameters. Data are presented as mean ± SD. *;  p<0.05, significance compare with control.
Number of male and female in each group is 3, respectively.140 Okjin Kim, Jin-Uk Lee
SD rats and ICR mice
There was no peritoneal inflammation in the SD rats in
this study even in those animals given a high dose (Table 1).
There was also an absence of peritoneal inflammation in the
mice (Table 1). Although sudden death occurred in the
group of mice given a high dose of the drug, the pathological
lesions were not related to peritonitis. These mice showed
severe hemorrhagic changes in the gastrointestinal tract.
Discussion
Despite the advances in diagnosis, surgery, antimicrobial
therapy, and intensive care support, the mortality rate in
humans with severe peritonitis remains high [4]. In this
study, the macroscopic findings of induced experimental
peritonitis in Mongolian gerbils were similar to those of
clinical peritonitis observed in humans. The parietal
peritoneum was thickened and adhered to the abdominal
organs. The entire gastrointestinal tract was covered with a
thin fibrous film and the mesentery was thickened and
contracted. The use of the Mongolian gerbil as an animal
model for peritonitis might contribute to determining the
mechanisms of clinical peritonitis in humans, and may also
help in establishing the therapeutic treatment by screening
drugs for preventing peritonitis.
In this study, an animal model, the Mongolian gerbil, was
used to develop experimental peritonitis using an oral dose
of indomethacin, a nonsteroidal anti-inflammatory drug
(NSAID), which is widely used as an analgesic, anti-
inflammatory and antipyretic. The main concern for these
drugs is the frequency and severity of their digestive side
effects involving the entire gastrointestinal tract. The fecal
calprotectin is altered in 44% [17] of patients taking
NSAID, and scintigrams suggest the presence of small
intestinal inflammation in 42% of cases. However, when
fecal excretion of [
111In]-labeled leukocytes was used as a
measure of inflammation, up to 67% [13] of patients were
found to have enteropathy. Similarly, in a post-mortem
study, intestinal lesions were detected by enteroscopy [10] in
66% of patients, and 13.5% of subjects had nonspecific
intestinal ulceration [1]. The intestinal lesions caused by
NSAID can mimic inflammatory bowel disease [9] and
might lead to chronic bleeding, protein loss, strictures,
diverticulitis, appendicitis, internal fistulas, and a relapse of
Table 2. Hematological analysis on 5 days after oral administration of indomethacin in Mongolian gerbil
Items
Indomethacin (mg/kg body weight)
0 2 03 04 0
Male Female Male Female Male Female Male Female
WBC (10
3/mm
3) 04.7 ± 0.43 05.4 ± 0.57 05.5 ± 0.69 05.8 ± 0.83 010.5 ± 1.04*009.8 ± 0.91*013.2 ± 1.54*012.9 ± 1.07*
RBC (10
6/mm
3) 06.2 ± 0.95 07.1 ± 0.63 07.4 ± 0.75 07.1 ± 0.69 07.4 ± 0.87 07.8 ± 0.96 07.3 ± 1.01 07.2 ± 0.97
Hb (g/dl) 11.3 ± 1.54 13.5 ± 1.78 13.4 ± 0.75 11.2 ± 1.35 12.7 ± 0.96 13.6 ± 1.07 12.8 ± 1.16 13.1 ± 1.52
Hct (%) 40.2 ± 1.57 41.3 ± 1.63 45.0 ± 2.01 42.8 ± 1.84 43.6 ± 1.47 42.8 ± 1.59 43.5 ± 1.83 41.8 ± 2.47
Platelet (10
3/mm
3) 572 ± 3.4. 563 ± 2.9. 534 ± 2.5. 545 ± 3.0.. 247 ± 1.9* .255 ± 3.2* .215 ± 2.5* .211 ± 3.2*
MCV um
3 .62 ± 1.0 .63 ± 1.9 .58 ± 1.3 .59 ± 1.5 .61 ± 1.5 .59 ± 2.1 .58 ± 2.7 .61 ± 2.6
MCH (pg) 18.8 ± 1.53 18.6 ± 1.17 18.2 ± 1.21 18.1 ± 1.04 17.9 ± 1.17 19.1 ± 1.09 18.5 ± 1.32 18.1 ± 0.98
MCHC g/dl 32.6 ± 2.36 30.6 ± 3.90 31.4 ± 1.57 34.0 ± 2.75 32.5 ± 2.51 31.6 ± 2.24 33.5 ± 1.76 32.8 ± 2.47
Note: Data are presented as mean ± SD. *;  p<0.05, significance from the value of control. WBC; white blood cell, RBC; red blood cell, Hb;
hemoglobin, Hct; hematocrit, MCV; mean corpuscular volume, MCH; mean corpuscular hemoglobin, MCHC; mean corpuscular hemoglobin
concentration. Number of male and female in each group is 3, respectively.
Table 3. Biochemical analysis on 5 days after oral administration of indomethacin in Mongolian gerbil
Items 
Indomethacin (mg/kg body weight)
0 2 03 04 0
Male Female Male Female Male Female Male Female
AST (U/l) 165.1 ± 7.42 181.6 ± 3.51 182.5 ± 5.62 198.5 ± 6.55 259.8 ± 6.43*238.5 ± 7.02*352.5 ± 5.93*396.5 ± 6.95*
ALT (U/l) 040.5 ± 2.51 039.6 ± 1.54 044.6 ± 2.06 045.5 ± 2.53 054.8 ± 2.85*053.4 ± 1.86*071.5 ± 1.91*076.3 ± 1.98*
T-protein (g/dl) 05.62 ± 0.53 06.01 ± 0.56 05.45 ± 0.95 05.75 ± 1.01 04.52 ± 1.35*04.35 ± 1.12*04.09 ± 1.25*04.11 ± 1.22*
Albumin (g/dl) 04.59 ± 1.55 04.35 ± 1.52 04.38 ± 1.03 04.29 ± 1.85 04.01 ± 1.02*03.85 ± 0.36*03.56 ± 0.94*03.85 ± 0.56*
BUN (mg/dl) 023.6 ± 1.52 025.9 ± 1.91 029.5 ± 1.59 028.5 ± 1.65 034.6 ± 2.51*035.4 ± 2.05*042.5 ± 1.85*041.9 ± 1.76*
Creatinine (mg/dl) 00.98 ± 0.24 00.85 ± 0.21 01.05 ± 0.16 01.01 ± 0.21 0.96 ± 0.12 1.05 ± 0.10 1.02 ± 0.22 1.05 ± 0.25
Note: Data are presented as mean ± SD. *;  p<0.05, significance from the value of control. AST; aspartate aminotransferase, ALT; alanine
aminotransferase, T-protein; total protein, BUN; blood urea nitrogen. Number of male and female in each group is 3, respectivel y.Indomethacin-induced peritonitis in Mongolian gerbils 141
inflammatory bowel disease. The pathogenesis of NSAID
enteropathy is complex and is not completely understood.
There are two main pathogenic mechanisms. The first
involves specific biochemical damage to the mitochondria
[15] with uncoupling of the oxidative phosphorylation
reaction. This increases the intestinal permeability and the
release of calcium into the cytosol, which in turn causes
secondary biochemical damage [2]. The second, and more
controversial mechanism involves the inhibition of
cyclooxygenase (COX) -1 and/or COX-2 and its products
(prostaglandins). However, some studies have reported that
COX inhibition is not involved [3], while another study
suggested that COX inhibition is the key event [16]. In this
study, indomethacin induced the dose-dependent and time-
dependent formation of macroscopically apparent peritoneal
lesions in Mongolian gerbils. Grossly, these animals showed
dark red and sticky material in the jejunum, ileum and an
enlarged colon. Histopathologically, the jejunum of these
animals had mucosal erosions and hemorrhagic lesions.
Histopathological scores of peritoneal inflammation were
significantly increased by the administration of indomethacin
(p < 0.05). Also, peritonitis was revealed by the significant
changes of WBC and platelet count (p < 0.05). The results
of biochemical analysis were evidenced the hepatic and
renal damages in group 3 and 4. The cause of the peritonitis
in this study suggests that it might be due to the increased
permeability of the jejunum caused by the administration of
indomethacin. Both total protein albumin level and histological
findings could suggest it.
This study found an effective and simple method of
inducing peritonitis by oral dosing of indomethacin at a rate
of 30 mg/kg body weight using 5-week old Mongolian
gerbils.  The resulting peritonitis that developed can be used
as an effective tool for investigating the potential therapeutic
compounds aimed at preventing peritoneal damage during
peritonitis and provide insight into the pathophysiology of
peritonitis.
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